There is a considerable shift in the perception of Constellation Brands STZ's market position. Despite the company's recent struggles, there's a belief it is positioned for future success. Several factors such as tariffs and lowered growth forecasts have dampened market sentiment. Price target for STZ has been downgraded by both RBC Capital and Bernstein to $289 and $230 respectively. Multiple fraud lawsuits are brewing in the wake of investor losses. Analysts have been divided over whether the stock is a buy, sell, or hold. However, in a surprising move, Warren Buffett's Berkshire Hathaway invested extensively in the company, triggering a stock surge. Finally, STZ plans to invest hugely in cannabis producer Canopy Growth enhancing its global positioning. Despite an influx of negative news over the past year, systematic institutional investor ownership and recent strategic moves seem to underline confidence in STZ's long-term prospects.
Constellation Brands STZ News Analytics from Wed, 15 Aug 2018 07:00:00 GMT to Sat, 08 Mar 2025 16:57:44 GMT -
Rating -2
- Innovation -1
- Information 2
- Rumor -3
